• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新利用药物托溴铵溴化物对宿主口腔-肠道微生物组的影响。

Impact of the repurposed drug thonzonium bromide on host oral-gut microbiomes.

机构信息

Biofilm Research Labs, Levy Center for Oral Health, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.

Department of Orthodontics and divisions of Pediatric Dentistry & Community Oral Health, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.

出版信息

NPJ Biofilms Microbiomes. 2021 Jan 22;7(1):7. doi: 10.1038/s41522-020-00181-5.

DOI:10.1038/s41522-020-00181-5
PMID:33483519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7822857/
Abstract

Drug repurposing is a feasible strategy for the development of novel therapeutic applications. However, its potential use for oral treatments and impact on host microbiota remain underexplored. Here, we assessed the influences of topical oral applications of a repurposed FDA-approved drug, thonzonium bromide, on gastrointestinal microbiomes and host tissues in a rat model of dental caries designed to reduce cross-contamination associated with coprophagy. Using this model, we recapitulated the body site microbiota that mirrored the human microbiome profile. Oral microbiota was perturbed by the treatments with specific disruption of Rothia and Veillonella without affecting the global composition of the fecal microbiome. However, disturbances in the oral-gut microbial interactions were identified using nestedness and machine learning, showing increased sharing of oral taxon Sutterella in the gut microbiota. Host-tissue analyses revealed caries reduction on teeth by thonzonium bromide without cytotoxic effects, indicating bioactivity and biocompatibility when used orally. Altogether, we demonstrate how an oral treatment using a repurposed drug causes localized microbial disturbances and therapeutic effects while promoting turnover of specific oral species in the lower gut in vivo.

摘要

药物再利用是开发新的治疗应用的可行策略。然而,其在口服治疗中的潜在用途及其对宿主微生物群的影响仍未得到充分探索。在这里,我们评估了局部口腔应用一种经过重新利用的 FDA 批准药物——溴化硫柳汞对龋齿大鼠模型中胃肠道微生物群和宿主组织的影响,该模型旨在减少与食粪相关的交叉污染。使用这种模型,我们重现了与人类微生物组特征相匹配的体部位微生物群。口腔微生物群受到治疗的干扰,特定地破坏了罗特氏菌属和韦荣氏球菌属,而不会影响粪便微生物群的整体组成。然而,使用嵌套和机器学习识别出了口腔-肠道微生物相互作用的干扰,表明肠道微生物群中口腔分类群萨特氏菌的共享增加。宿主组织分析显示,溴化硫柳汞可减少牙齿龋齿,且无细胞毒性作用,表明其口服使用具有生物活性和生物相容性。总的来说,我们展示了一种使用重新利用药物的口服治疗如何在体内引起局部微生物紊乱和治疗效果,同时促进特定口腔物种在下肠道的更替。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa7/7822857/8aa5c9523007/41522_2020_181_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa7/7822857/0781cd9c6bbf/41522_2020_181_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa7/7822857/66a576dbd188/41522_2020_181_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa7/7822857/8a15803a5c2d/41522_2020_181_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa7/7822857/bd0add7f8da9/41522_2020_181_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa7/7822857/8aa5c9523007/41522_2020_181_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa7/7822857/0781cd9c6bbf/41522_2020_181_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa7/7822857/66a576dbd188/41522_2020_181_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa7/7822857/8a15803a5c2d/41522_2020_181_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa7/7822857/bd0add7f8da9/41522_2020_181_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa7/7822857/8aa5c9523007/41522_2020_181_Fig5_HTML.jpg

相似文献

1
Impact of the repurposed drug thonzonium bromide on host oral-gut microbiomes.重新利用药物托溴铵溴化物对宿主口腔-肠道微生物组的影响。
NPJ Biofilms Microbiomes. 2021 Jan 22;7(1):7. doi: 10.1038/s41522-020-00181-5.
2
Host Genetic Control of the Oral Microbiome in Health and Disease.口腔微生物组的宿主遗传控制:健康与疾病。
Cell Host Microbe. 2017 Sep 13;22(3):269-278.e3. doi: 10.1016/j.chom.2017.08.013.
3
Multi-omics Approaches To Decipher the Impact of Diet and Host Physiology on the Mammalian Gut Microbiome.多组学方法解析饮食和宿主生理学对哺乳动物肠道微生物组的影响。
Appl Environ Microbiol. 2020 Nov 10;86(23). doi: 10.1128/AEM.01864-20.
4
Impact of traditional Chinese medicine treatment on chronic unpredictable mild stress-induced depression-like behaviors: intestinal microbiota and gut microbiome function.中药治疗对慢性不可预测轻度应激诱导的抑郁样行为的影响:肠道微生物群和肠道微生物组功能。
Food Funct. 2019 Sep 1;10(9):5886-5897. doi: 10.1039/c9fo00399a. Epub 2019 Aug 29.
5
Comparison of different modes of antibiotic delivery on gut microbiota depletion efficiency and body composition in mouse.比较不同模式的抗生素给药对小鼠肠道微生物群耗竭效率和身体成分的影响。
BMC Microbiol. 2020 Nov 11;20(1):340. doi: 10.1186/s12866-020-02018-9.
6
An in vitro evaluation of the effects of different statins on the structure and function of human gut bacterial community.体外评价不同他汀类药物对人类肠道细菌群落结构和功能的影响。
PLoS One. 2020 Mar 26;15(3):e0230200. doi: 10.1371/journal.pone.0230200. eCollection 2020.
7
The Oral Microbiome in the Elderly With Dental Caries and Health.老年人的口腔微生物组与龋齿和健康。
Front Cell Infect Microbiol. 2019 Jan 4;8:442. doi: 10.3389/fcimb.2018.00442. eCollection 2018.
8
Relationship between oral and gut microbiota in elderly people.老年人的口腔和肠道微生物群之间的关系。
Immun Inflamm Dis. 2019 Sep;7(3):229-236. doi: 10.1002/iid3.266. Epub 2019 Jul 15.
9
Impact of lincosamides antibiotics on the composition of the rat gut microbiota and the metabolite profile of plasma and feces.林可酰胺类抗生素对大鼠肠道微生物群落组成和血浆及粪便代谢物谱的影响。
Toxicol Lett. 2018 Oct 15;296:139-151. doi: 10.1016/j.toxlet.2018.08.002. Epub 2018 Aug 10.
10
The Impact of Anthelmintic Treatment on Human Gut Microbiota Based on Cross-Sectional and Pre- and Postdeworming Comparisons in Western Kenya.基于肯尼亚西部的横断面和驱虫前后比较的驱虫治疗对人类肠道微生物群的影响。
mBio. 2019 Apr 23;10(2):e00519-19. doi: 10.1128/mBio.00519-19.

引用本文的文献

1
Thonzonium bromide inhibits progression of malignant pleural mesothelioma through regulation of ERK1/2 and p38 pathways and mitochondrial uncoupling.溴化噻唑鎓通过调节ERK1/2和p38信号通路以及线粒体解偶联来抑制恶性胸膜间皮瘤的进展。
Cancer Cell Int. 2024 Jun 29;24(1):226. doi: 10.1186/s12935-024-03400-7.
2
Standardized studies of the oral microbiome: From technology-driven to hypothesis-driven.口腔微生物组的标准化研究:从技术驱动到假设驱动
Imeta. 2022 Apr 11;1(2):e19. doi: 10.1002/imt2.19. eCollection 2022 Jun.
3
A high-throughput screening approach to discover potential colorectal cancer chemotherapeutics: Repurposing drugs to disrupt 14-3-3 protein-BAD interactions.

本文引用的文献

1
The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis.口腔与肠道共生菌驱动的结肠炎中的黏膜连接。
Cell. 2020 Jul 23;182(2):447-462.e14. doi: 10.1016/j.cell.2020.05.048. Epub 2020 Jun 16.
2
Periodontitis and inflammatory bowel disease: a meta-analysis.牙周炎与炎症性肠病:一项荟萃分析。
BMC Oral Health. 2020 Mar 12;20(1):67. doi: 10.1186/s12903-020-1053-5.
3
Identification of repositionable drugs with novel antimycotic activity by screening the Prestwick Chemical Library against emerging invasive moulds.
一种发现潜在结直肠癌化疗药物的高通量筛选方法:重新利用药物破坏14-3-3蛋白与BAD的相互作用。
bioRxiv. 2023 Dec 15:2023.12.14.571727. doi: 10.1101/2023.12.14.571727.
4
Discovery and mechanism of action of Thonzonium bromide from an FDA-approved drug library with potent and broad-spectrum inhibitory activity against main proteases of human coronaviruses.从美国食品和药物管理局批准的药物库中发现并研究了溴托铵的作用机制,其对人类冠状病毒的主要蛋白酶具有强大且广谱的抑制活性。
Bioorg Chem. 2023 Jan;130:106264. doi: 10.1016/j.bioorg.2022.106264. Epub 2022 Nov 9.
5
Farnesol delivery via polymeric nanoparticle carriers inhibits cariogenic cross-kingdom biofilms and prevents enamel demineralization.聚合物纳米颗粒载体传递法尼醇可抑制致龋跨界生物膜并防止牙釉质脱矿。
Mol Oral Microbiol. 2022 Oct;37(5):218-228. doi: 10.1111/omi.12379. Epub 2022 Aug 4.
通过针对新兴侵袭性霉菌筛选普瑞威克化学文库来鉴定具有新型抗真菌活性的可重新定位药物。
J Glob Antimicrob Resist. 2020 Jun;21:314-317. doi: 10.1016/j.jgar.2020.01.002. Epub 2020 Jan 28.
4
Impact of commonly used drugs on the composition and metabolic function of the gut microbiota.常用药物对肠道微生物群落组成和代谢功能的影响。
Nat Commun. 2020 Jan 17;11(1):362. doi: 10.1038/s41467-019-14177-z.
5
Repurposing auranofin as a Clostridioides difficile therapeutic.将金诺芬重新用作艰难梭菌治疗药物。
J Antimicrob Chemother. 2020 Feb 1;75(2):409-417. doi: 10.1093/jac/dkz430.
6
Time-Course Transcriptome Analysis for Drug Repositioning in -Infected Human Gingival Fibroblasts.感染人牙龈成纤维细胞中药物重新定位的时间进程转录组分析
Front Cell Dev Biol. 2019 Sep 20;7:204. doi: 10.3389/fcell.2019.00204. eCollection 2019.
7
A wild microbiome improves mouse modeling of the human immune response.野生微生物群改善了人类免疫反应的小鼠模型。
Lab Anim (NY). 2019 Nov;48(11):337-338. doi: 10.1038/s41684-019-0421-8.
8
Regional Diversity of the Gastrointestinal Microbiome.肠道微生物组的区域多样性。
Cell Host Microbe. 2019 Sep 11;26(3):314-324. doi: 10.1016/j.chom.2019.08.011.
9
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2.使用QIIME 2进行可重复、交互式、可扩展和可延伸的微生物组数据科学研究。
Nat Biotechnol. 2019 Aug;37(8):852-857. doi: 10.1038/s41587-019-0209-9.
10
Novel zafirlukast derivatives exhibit selective antibacterial activity against .新型扎鲁司特衍生物对……具有选择性抗菌活性。
Medchemcomm. 2019 Jun 10;10(6):926-933. doi: 10.1039/c9md00074g. eCollection 2019 Jun 1.